Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Efficacy of BDP HFA Nasal Aerosol in PAR
NCT00988247Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in perennial allergic rhinitis (PAR), sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2009; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00988247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988247.